Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Hepatitis C virus nonstructural proteins NS3–NS5B are virally encoded enzymes and regulatory proteins that play essential roles in the replication cycle of hepatitis C virus (HCV), a positive-sense single-stranded RNA virus. NS3 functions as both a serine protease—critical for cleaving the viral polyprotein into functional units—and as an RNA helicase/NTPase, required for unwinding RNA during genome replication. NS5B is the viral RNA-dependent RNA polymerase, directly responsible for synthesizing new copies of the viral genome. NS4A acts as a cofactor for NS3, NS4B organizes replication complex assembly on altered host membranes, and NS5A is a phosphoprotein coordinating replication and virion assembly[1][4][5]. Together, NS3–NS5B constitute the main "replication module" (replicase) of HCV, forming a membrane-associated multiprotein complex essential for viral RNA synthesis and persistence. As such, NS3, NS5A, and NS5B are all validated therapeutic targets for direct-acting antiviral drugs, which have revolutionized hepatitis C therapy by specifically inhibiting these proteins and thereby blocking viral replication and cure infection in most patients[1][4][5][7].
Inhibition of NS3/4A protease blocks viral polyprotein processing and replication; Inhibition of NS5A disrupts replication complex assembly and viral RNA replication; Inhibition of NS5B RNA-dependent RNA polymerase prevents new viral RNA synthesis
12 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Hepatitis C virus nonstructural protein 3–5B (HCV NS3–NS5B).